Camlin Fine Sciences has informed that the Company has allotted 12,250 equity shares of face value of Re 1 each in accordance with the terms of ESOP 2018, on 11th June, 2021. Consequent to the said allotment the paid-up share capital of the Company has gone up to 127591371 equity shares of face value of Re 1 each aggregating to Rs 12,75,91,371. The said shares have been listed on the exchanges on 18th June, 2021.
The above information is a part of company’s filings submitted to BSE.